Sun Pharma's $11.75 Billion Organon Acquisition Signals India's Most Ambitious Pharmaceutical Expansion
Sun Pharma Organon acquisition: $11.75B deal boosts global presence, biosimilars entry, and revenues to $12.4B. Full analysis of risks, strategy, and impact.
